Contact Info
- 65 Sprague St.
- West B
- Boston, MA 02136
- Website: http://www.solosendoscopy.com/
- Phone: 617-360-9700
- Email: info@solosendoscopy.com
Update Company Info
Business Description
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.
Financial Reporting/Disclosure
| Reporting Status | Alternative Reporting Standard |
| Audited Financials | Not Available |
| Latest Report | May 15, 2012 Quarterly Report |
| Regulatory Agency | Not Available |
| CIK | 0001388994 |
| Fiscal Year End | 12/31 |
| OTC Market Tier | OTC Pink Current |
Profile Data
| SIC - Industry Classification | 3841 - Surgical and medical instruments |
| Incorporated In: | NV, USA |
| Year of Inc. | 1986 |
| Employees | 4 a/o Dec 31, 2009 |
Company Officers
| Robert Segersten | President |
| Fred Schiemann | CFO |
| Amanda Segersten | Vice President |
| Jason Takacs | IR |
Company Directors
| Fred Schiemann |
Company Notes
- Formerly=ViaDux Health, Inc. until 3-06
- Formerly=Prime Capital Resources, Inc. until 9-16-05. State of Incorporation Florida changed to Nevada concurrent with name change
- Formerly=MobileVest, Inc. until 8-02
Service Providers
Auditor/Accountant Legal Counsel
Not Available
Investor Relations Firm
SNDY Security Details
Share Structure
| Market Value1 | $2,793,822 | a/o May 24, 2012 |
| Shares Outstanding | 404,901,710 | a/o Dec 31, 2011 |
| Float | 239,556,215 | a/o Dec 31, 2011 |
| Authorized Shares | 500,000,000 | a/o Dec 31, 2011 |
| Par Value | 0.001 |
Shareholders
| Shareholders of Record | 587 | a/o Dec 31, 2011 |
Short Selling Data
| Short Interest | 11,999 (27,804.65%) May 15, 2012 |
| Significant Failures to Deliver | No |
Transfer Agent(s)
| Pacific Stock Transfer Co. |
1Market Value calculated only for respective security




